1,776
edits
Line 44: | Line 44: | ||
* [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/EAB_Meeting_Agenda_2017.11.01.pdf Agenda] | * [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/EAB_Meeting_Agenda_2017.11.01.pdf Agenda] | ||
* [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/2016_Consolidated_EAB_Recommendations.pdf 2016 Consolidated EAB Recommendations] | * [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/2016_Consolidated_EAB_Recommendations.pdf 2016 Consolidated EAB Recommendations] | ||
* Presentations: | |||
** [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/2.%20EAB%20Page_iDigBio%20Summit%20Report%2C%20vers.3.pdf State of iDigBio & Primary Issues for EAB] by Larry Page | |||
** [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/EAB%20Soltis%20data%20use%20-%20research%20final2%20comp.pdf iDigBio Data Use] by Pam Soltis | |||
** [https://www.idigbio.org/sites/default/files/internal-docs/eab/2017-11/2017_EAB_Metrics_final.pdf Metrics & Statistics] by David Jennings | |||
== November 1, 2016 == | == November 1, 2016 == |